Anúncio
Anúncio

JAGX

JAGX logo

Jaguar Health, Inc.

1.05
USD
Patrocinado
-0.03
-2.31%
09 de jan., 15:05 UTC -5
Abrir

Relatórios de Lucros JAGX

Rácio de surpresa positiva

JAGX separação 13 de 30 últimas estimativas.

43%

Próximo Relatório

Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$4.30M
/
-$4.34
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+39.32%
/
-30.89%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+23.96%
/
+1176.47%

Jaguar Health, Inc. earnings per share and revenue

On 18 de nov. de 2025, JAGX reported earnings of -6.28 USD per share (EPS) for Q3 25, missing the estimate of -5.18 USD, resulting in a -21.20% surprise. Revenue reached 3.08 milhão, compared to an expected 3.80 milhão, with a -18.97% difference. The market reacted with a -8.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -4.34 USD, with revenue projected to reach 4.30 milhão USD, implying an diminuir of -30.89% EPS, and aumentar of 39.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Jaguar Health, Inc. reported EPS of -$6.28, missing estimates by -21.2%, and revenue of $3.08M, -18.97% below expectations.
The stock price moved down -8.03%, changed from $1.80 before the earnings release to $1.66 the day after.
The next earning report is scheduled for 30 de mar. de 2026.
Based on 3 analistas, Jaguar Health, Inc. is expected to report EPS of -$4.34 and revenue of $4.30M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio